secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001193125-25-096692
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma receives Nasdaq notice for non-compliance with $1.00 minimum bid price rule
--------------------------------------------------------------------------------

- Notice received April 22, 2025; stock below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until Oct 20, 2025) to regain compliance.
- To cure, bid price must close at $1.00+ for 10 consecutive business days.
- May transfer to Nasdaq Capital Market for an additional 180-day grace period if needed.
- If not cured, stock faces potential delisting; company is evaluating options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525096692/0001193125-25-096692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525096692/d898205d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-096692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer